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INTRODUCTION 
 
Not until recently, the importance of nutrition in the critically ill patients was disregarded, as 
the focus was primarily directed towards curative therapy. Nutritional supplementation was 
thought to have a less significant impact on the final outcome of the diseases. Later, 
physicians started to realize the role nutrition plays in the recovery of patients. Malnutrition 
severely impairs the healing, the therapeutic outcome, the quality of life, the hospital stay, and 
thus the cost of care. Early postoperative nutrition benefits surgical patients by decreasing 
septic morbidity, maintaining immunocompetence, and improving wound healing. 
Patients with head and neck cancers are at particular risk for malnutrition. Malnourishment is 
the result of several local and systemic factors. Alcoholism, smoking and poor diet have a 
high prevalence in patients with head and neck cancers leading to decreased protein, vitamins 
and minerals uptake. Local tumor growth can cause dysphagia, odynophagia, smell and taste 
distortion, and aspiration. On the other hand increased metabolic rate of cancer cells and 
accelerated protein catabolism require high calorie and protein diet to maintain nutritional 
balance. Surgery causes anatomical alterations, pain, dysmotility, and can predispose to 
aspiration further worsening the ability of proper alimentation. Mucositis, pain, edema, 
nausea and xerostomia as the result of radio-, and chemotherapy all have an adverse effect on 
feeding. All of these factors finally deplete the protein and fat stores of the body, leading to 
severe weight loss, impairing the immune function and resulting in progressive protein-calorie 
malnutrition. For these reasons, patients with head and neck cancer require continuous 
nutritional assessment and adequate calorie-protein supplementation.  
 
 
ARTIFICIAL NUTRITION 
 
Proper diet of patients with head and neck cancer is essential. ”When the gut works, use it” 
should be a common sense practice of physicians dealing with nutritional care. More and 
more data suggest in the literature that enteral feeding is not just more natural way of 
administering food but also has a positive influence on the recovery of patients. Not only the 
quantity and quality of food that matters, but also the route of alimentation. A normal well-fed 
intestine besides absorbing nutrients, also maintains a protective barrier against intraluminal 
toxins and bacteria. Peristalsis, secretory Immunoglobulin A, mucin and an intact mucosa 
have a protective and supportive role to achieve this function. Changes in the structure of 
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gastrointestinal mucosa, increases the permeability to bacteria and toxins, results in bacterial 
colonization and translocation, and alters the immunologic function of the gut. Enteral feeding 
leads to a reduced rate of surgical complications. 
 
 
ENTERAL FEEDING 
 
The nasogastric tube feeding is the most common in head and neck cancer patients. However 
the introduction of percutaneous endoscopic gastrostomy (PEG) in clinical practice by 
Gauderer and Ponsky in 1980, has revolutionized our practice. This PhD focuses on 
percutaneous endoscopic gastrostomy and its aspects in head and neck cancer patients.  
 
 
Historical background of PEG 
 
Dr. Jeffrey Ponsky, pediatric gastroenterologist and Dr. Michael Gauderer pediatric surgeon, 
both worked in Cleveland, USA note while performing upper gastrointestinal endoscopy in 
small children the ease and simplicity with which the anterior abdominal wall could be 
transilluminated, indicating the close contact between the abdominal and gastric walls. This 
gave them the idea to work out the details of a technique that would allow percutaneous 
puncture of the insufflated and transilluminated stomach under endoscopic control for 
gastrostomy tube placement. The original kit used was a home-made 16-F de Pezzer latex 
tube with a tapered intravenous cannula fitted to its distal end. The first five cases (all babies) 
of percutaneous endoscopic gastrostomy were presented at the annual meeting of The 
American Society of Gastrointestinal Endoscopy in May 1980. The method was welcomed 
and rapidly recognized by the gastroenterologist, but initially looked upon with skepticism by 
the surgeons. Soon PEG gained wide acceptance as a safe, simple and efficient method of 
providing nutritional support in patients with variety of pathologies. The general indication 
for percutaneous endoscopic gastrostomy is summarized in Table 1. The maintenance of 
nutrition and fluid balance during the treatment of head and neck tumors is one of the most 
important indications for PEG placement. More than 216,000 PEGs are performed annually in 
the United States and thus it is the second most common indication for upper gastrointestinal 
endoscopy.  
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GENERAL INDICATIONS FOR PEG PLACEMENT 
 
I. LONG-TERM NUTRITION 
• Head and neck tumors. 
• After an acute stroke 
• Extensive traumatic injury. 
• Neurological disorder 
• Growth failure in children.  
• Other hyperkatabolic states 
 
 
II. DECOMPRESSION 
• Diabetic gastroparesis  
• Intestinal pseudo-obstruction 
• Mechanical obstruction  
III. OTHERS 
• gastric volvulus / gastric fixation  
• formation of biliogastric shunt  
• to deliver pharmacotherapy  
• access “avenue” to stomach 
Table 1. 
 
 
PEG IN HEAD AND NECK CANCERS 
 
Percutaneous endoscopic gastrostomy is usually a straightforward procedure in cases of 
neurological indication, but certain technical aspects and clinical applications should be 
strongly considered when indicated for patients with head and neck malignancies. The 
insertion methods, the placement routes, and the timing of PEG insertion require certain 
adaptation and modification of the usual PEG procedure.  
 
 
INSERTION METHODS OF PEG 
 
Mainly, “pull”, “push”, and “poke” methods are in use for PEG insertion. The “pull method” 
originally described by Gauderer and Ponsky in 1980, has changed little since its introduction 
and remained the most popular method of PEG tube placement. Percutaneous endoscopic 
gastrostomy procedures were started in the University of Pécs, Medical School, ENT 
Department with the collaboration of the Department of Internal Medicine on the 7th of 
January 1997. Most often the “pull method” is used in our department. The insertion is carried 
out “lege artis” according to the recommended procedure protocols. Initially antibiotic 
prophylaxis was not used, however later one dose of broad-spectrum antibiotic was given 
routinely to PEG patients prior to the procedure.  
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The “push method” is similar to the “pull method” except that the feeding tube is pushed over 
a guide wire. A flexible wire is passed via the needle-cannula instead of the suture used in the 
“pull-technique”, and retracted through the patient’s mouth by a snare. Specially designed 
PEG tube is pushed over the wire and eventually withdrawn. The advantage of this technique 
is that the operator has full control over the tube at all times. 
The “poke” or “introducer” method is basically a Seldinger technique. Under direct 
gastroscopic visualization the stomach is punctured and the tract is serially dilated by a dilator 
peel-away sheath. To keep the stomach approximated to the abdominal wall during the 
introduction, T-fasteners are usually needed. The potential advantages and disadvantages of 
the different techniques are listed in Table 2. 
 
Advantages and disadvantages of various PEG methods in head and neck cancer patient 
 
Table 2. 
 
PEG TECHNIQUES ADVANTAGES  DISADVANTAGES 
 
 
“pull-back” or “push” 
PEG with  
second-look gastroscopy 
 
 
 
• relatively easy procedure 
• quick 
 
 
•double gastroscopy 
• increased procedure-related 
risks and complications 
• increased risk for bacterial 
translocation and tumor cell  
seeding 
•  double discomfort 
 
 
“introducer” PEG 
 
 
 
• single gastroscopy 
• direct insertion of the 
feeding tube 
• technically demanding 
• extra gastric punctures (T-
fasteners) 
• higher complication rate 
• time consuming 
“pull-back” or “push” 
PEG with single pass of 
gastroscope  
without second-look 
• easier 
• shorter procedure 
• no second per oral 
gastroscopy 
• no second look, no chance to 
exclude disposition of tube or any 
complication 
• more experience needed for 
positioning the feeding tube 
“pull-back” or “push” 
PEG with single pass of 
gastroscope with  
“trans-tubal” fiberscopy 
for second-look 
 
• option for second-look 
• less discomfort for         
patient 
• decreased gastroscopy-
related risks and 
complications 
• additional scope needed 
• additional experience needed 
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The need for the second introduction of the gastroscope during PEG placement has a 
significance in patients with head and neck cancer. First, every procedure, so does the 
endoscopy has its own risks. A study reviewing the literature on endoscopic complications, 
lists 4 major and 45 minor complications related to gastroscopy. Although, the overall 
incidence of complications in routine cases is not high (0.1%), the chance of causing 
perforation or hemorrhage in patients with head and neck cancer is greater.  
Second, there are additional risks when gastroscopy is done in cancer patients for creating a 
PEG. The repeated pass of the gastroscope increases the chance of tumor cell seeding to the 
stoma site and the risk of bacterial translocation causing peristomal infection. In addition, 
manipulation around the laryngeal or hypopharyngeal area with tumor growth can cause 
edema, further compromising the airway. 
Third, the pass of the gastroscope can be very difficult in an area with extensive tumor mass 
or major postoperative anatomical changes. Technical details about how to avoid some of 
these problems will be discussed under the chapter “Placement routes of PEG”. 
Last but not least, gastroscopy causes discomfort for the patient unless carried out in general 
anesthesia.  
In sum, the second pass of the gastroscope during the “pull” or “push” method basically 
increases the risks of the above-mentioned problems. Though “introducer’ method allows 
single gastroscopy, this technique is time consuming, technically more demanding, and 
increases the chance of some major procedure-related risks and complications. Thus, it is not 
in a routine clinical use.  
In order to keep the advantages and to eliminate the disadvantages of the different PEG 
methods, the author has introduced a novel technical modification. In this method a “pull-
back” or “push” type PEG is inserted in a traditional fashion but instead of the second per oral 
gastroscopy, a flexible laryngofiberscope is passed via the inserted feeding tube to provide the 
option for a “second-look”.  
“Transtubal” fiberscopy can play a role in checking the correct position of the feeding tube 
and in excluding complications. It can be performed in most cases when otherwise a second 
per oral gastroscopy is planned.  
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ALTERNATIVE TECHNIQUES FOR CREATING GASTROSTOMIES 
 
There are several other options to create gastrostomy for patients with head and neck cancers, 
who are not fit for gastroscopy due to different reasons (e.g. extensive obstructing tumor 
mass). Percutaneous radiologic gastrostomy (PRG) is one of the most commonly used for 
creating gastrostomy for patients with head and neck cancer. Detailed discussion about PRG 
is beyond the scope of this PhD.  
 
 
PLACEMENT ROUTES OF PEG 
 
The route of introducing the gastroscope into the stomach is one of the crucial points of PEG 
procedures in head and neck cancer patients. Mainly, percutaneous endoscopic gastrostomy is 
carried out by passing both the gastroscope, and the feeding tube through the oral cavity. 
However, one of the main hurdles for creating endoscopic gastrostomy in patients with head and 
neck cancers is the presence of the tumor mass that hinders the easy introduction of the 
gastroscope to the stomach. Tumors can block the way for gastroscopy either by narrowing the 
passage or by causing trismus, hemorrhage, edema or severe pain. To overcome such problems 
one can use pediatric or ultra-thin gastroscopes. In other cases it can be very challenging for the 
gastroenterologist to find the way down to the stomach by a flexible scope among massive tumor 
growth. Kleinsasser`s rigid direct laryngoscopy and the experience of ENT surgeon, who is 
familiar with the location and extent of the cancer, usually proves to be a good help, maneuvering 
the gastroscope into the esophagus. When the tumor mass is located in the oral cavity and causes 
obstruction or trismus, transnasal pass of both the gastroscope and feeding tube provides a 
solution. One of the complications, which can occur after major head and neck surgery, is the 
formation of cervical pharyngo-cutaneous fistula. Beside others, this is the result of narrow 
pharynx caused by postoperative anatomical changes or irradiation-induced fibrosis. None of the 
conventional techniques would allow endoscopic placement of gastrostomy feeding tube due to 
the narrow alimentary tract. However, author described and carried out PEG via the cervical 
fistula for such cases, avoiding the need for open. In case, the tumor is so extensive that hinders 
any type of endoscopy and the patient is scheduled for surgical resection, an ideal option is 
intraoperative PEG. After resection of the cancer, PEG can be inserted directly into the pharynx or 
esophagus through the opened operative field. The author was among the first to detail the method 
of intraoperative PEG insertion in Hungary (Table 3).  
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PLACEMENT ROUTES OF PEG 
 
1. Per oral with standard-size gastroscope 
2. Per oral with pediatric / ultra-thin gastroscopes 
3. Per oral-with assistance of Kleinsasser`s rigid laryngoscope 
4. Trans-nasal 
5. Via cervical fistula 
6. Trans-cervical during head and neck surgical procedure (intraoperative) 
Table 3. 
 
 
TIMING OF PEG 
 
Patients with head and neck malignancies are usually malnourished. Early nutritional support 
has a positive impact on the therapeutic outcome. Thus, timing of PEG is crucial in the 
nutritional and effective management of head and neck cancer patients. The use of 
percutaneous endoscopic gastrostomy and its timing should be considered individually based  
on the tumor’s extension, localization, the therapeutic plan, the possible outcome, and the 
expected life span of the patient. The experience of the treating physician is needed to 
evaluate all these factors in order to make the correct decision regarding when and how to 
create gastrostomy. Generally, PEG can be inserted prior to the definitive surgery, during the 
surgery or after the surgery. PEG is also inserted in non-surgical cases, for those receiving 
either curative or palliative radio- and/or chemotherapy or any other form of palliation.  
Preoperative insertion has the great advantage of early nutritional supplementation. As most of the 
head and neck cancer patients undergo staging panendoscopy and biopsy, it appears reasonable to 
insert PEG, if needed, at the same time in general anesthesia. It not only avoids an additional 
operative event for the patient, but also carries less procedure-related morbidity. There are reports 
suggesting higher incidence of acute cardio-vascular incidence during PEG insertion in local 
anesthesia for patients with head and neck cancers and also higher rate of perioperative PEG 
complication, if PEG is inserted before the tumor is resected. Beside the usual co-morbidities, the 
airways of these patients are often compromised by the tumor. General anesthesia with a secured 
airway by endotracheal intubation provides preferable protection during the PEG procedure in 
advanced malignancies. On the other hand preoperative PEGs have numerous disadvantages. 
Extensive tumors can block the passage of the gastroscope and the risk for tumor cell seeding 
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to the gastrostomy site is higher. Any arising complication due to PEG, can delay the time of 
definitive surgery. Last but not least, surgeon needs much more experience to decide at this 
early stage of management, whether patient really needs a gastrostomy. Intraoperative PEG is 
carried out via the opened pharynx immediately after the surgical resection of the tumor mass. 
Unimpeded passage of the gastroscope and feeding tube, no chance of tumor cell seeding and 
the lack of additional discomfort for the patient, are all in favor for intraoperative PEG. The 
risk for complications is reduced due to the protected airway by general anesthesia. Yet, 
drawbacks of intraoperative PEG are the extra time needed, and special preparation required 
for sterility (Table 5). Percutaneous endoscopic gastrostomy should not be indicated in the 
early postoperative period, as it is risky to pass the gastroscope and the feeding tube through a 
fresh surgical field with e.g. tenuous hypopharyngeal closure. 
Nasogastric tube is inserted during the surgery in most of these cases, anticipating that, the 
patient will regain the ability of normal per oral feeding and swallowing after the healing 
takes place. If this fails for any reason, and the patient needs nutritional supplementation 
longer than 4 weeks, it is recommended to change nasogastric tube to gastrostomy. Indication 
for PEG is obvious in such cases. However postoperative PEG means an additional surgical 
intervention with extra discomfort for the patient. Certain complications after major head and 
neck surgery and the altered anatomy, caused by the ablative surgery can make PEG 
insertion difficult. It would be desirable to indicate preoperative or intraoperative PEG in the 
first place to patients, whose tumor location, -extension, and the type of operation, allow the 
surgeon to anticipate the need for long-term nutrition.  
 
 
SPECIFIC INDICATIONS FOR PEG IN HEAD AND NECK CANCER  
 
The most important challenge for surgeons performing PEG placement is good patient 
selection. Patients undergoing resection of advanced-stage head and neck cancers often 
require weeks to months of rehabilitation before normal deglutition is achieved. This delay 
may be related to decreased oral competence due to resection of tissues needed for normal 
swallowing (e.g. tongue base), bulky reconstructive tissues, cranial nerve damage, or a 
combination of these factors. This delay of normal per oral feeding can be particularly 
prolonged by the side effects of postoperative radiotherapy. In order to set up a correct 
indication for PEG insertion in patients undergoing major head and neck surgeries, all the 
head and neck cancers treated in our ENT department in the last 7 years were worked up.   
 11 
PATIENTS AND METHODS 
 
1325 malignant head and neck cancer patients were treated as inpatients in the University of 
Pécs, Medical School, ENT Department between 7th of January 1997 and 31st of December 
2003. 1325 patients had 2125 hospital admissions over the 7-year-period. 177 (13%) patients 
were females and 1148 (87%) were males (Chart 1). 
Malignant tumours of males and females
females (# 177)
13%
males (# 1148)
87%
Chart 1 
 
The average age for females was 53 years (range 21-90 years) while it was 45 years (range 
17-93 years) for males. Of the 177 female patients 76 (43%) had laryngeal-, 14% had 
hypopharyngeal- and 7% had tonsillo-lingual cancers. 446 (39%) laryngeal-, 209 (18%) 
hypopharyngeal-, and 104 (9%) tonsillo-lingual cancers were diagnosed among the male 
patients with head and neck malignant tumors (Chart 2). The distribution of tumor sites was 
almost identical among the males and females (Chart 3). Overall, 41 % of the patients were 
treated with surgery, 10% with radiotherapy, and 10% with combination of surgery and 
radiotherapy. 30 % underwent diagnostic procedures only, and the remaining 9 % was 
admitted to the hospital for other reasons, such as e.g. palliation. Out of the 1325 patients with 
head and neck cancer, 676 patients had surgery (Chart 4). 23 different surgical procedures 
were performed on 834 occasions. The type and nature of the surgical procedures made it 
necessary in 559 cases, to insert a nasogastric tube or to create a gastrostomy for the recovery 
period. Unfortunately, missing and inaccurate data were only available regarding the exact 
number of nasogastric tube inserted and the time they were used, during the course of 
treatment in the different subgroups of oncology patients. 
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Tumor sites in head & neck cancer patients
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Chart 4 
 
Number of PEG procedures, timing of insertions, feeding days and replacements 
 
115 percutaneous endoscopic gastrostomies were carried out on 98 head and neck cancer 
patients in the University of Pécs, Medical School, ENT Department between 7th of January 
1997 and 31st of December 2003. The average age was 62 years (range 48-76 years) for 
female and 54 years (range 31-78 years) for the male patients. 73 PEGs were performed in 59 
patients in the postoperative period. 5 patients (6 PEGs) had preoperative, and 10 patients (11 
PEGs) had intraoperative PEG insertions. One patient each had PEG inserted twice from the 
preoperative and intraoperative groups. The second PEG procedure took place postoperatively 
in both cases. 25 PEGs (24 patients) were carried out as part of palliative treatment to provide 
nutritional support (Table 4). “Pull back” technique was used for PEG insertion, except for 
two cases of “push” technique. The insertion was performed either in general anesthesia or in 
sedation. The assistance of a rigid laryngoscope was used, whenever difficulty was 
encountered during the introduction of the gastroscope. “Second-look” endoscopy was always 
performed, either per orally, or via the inserted PEG feeding tube. PEG feeding was started 
gradually 12-24 hours after insertion, if postoperative assessment showed no signs for 
bleeding or leakage at the PEG site. 
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RESULTS 
The average number of feeding days through PEG was 307 in the postoperative group. This 
value was calculated from results of 66 PEGs, as the data were missing in 7 cases. The 
shortest duration of PEG feeding was 6 days, while the longest was 2403 days. Postoperative 
PEG insertions took place 84 days in average (range 4-283 days) after the definitive surgical 
resection. The mean PEG feeding duration was 316 days (range 40-534 days) in the 
intraoperative group and it was 81 days (range 10-143 days) in the preoperative group. 24 
patients had PEG as part of palliative therapy. The mean PEG feeding days in this group was 
142 days (range 5-554 days). 
In 10 postoperative patients the PEG had been permanently removed after 243 days in average 
(range 62-581 days), as adequate swallow function returned. In one preoperative case, PEG 
was removed on day 10 and in one palliative case on day 15, due to subsequent complication.  
11 patients had PEG insertion more than 1 time. PEG was change 4 times respectively in two 
patients, 3 times in another two patients and twice in 7 patients. Complication was the reason 
for PEG replacement in 12 cases. 5 PEGs were removed as adequate per oral feeding 
returned, but later PEG had to be reinserted due to e.g. recurrence of tumor.  
 
Tumor sites and types of surgical procedures 
 
20 tonsillo-lingual-, 7 tongue base-, 2 tongue-, 5 sublingual-, 10 supraglottic-, and 7 
hypopharyngeal cancers were diagnosed in the surgical groups with PEG. 16 cancers involved 
multiple sites and 7 were localized elsewhere (Chart 5). 13 of the 16 multiple site cancers 
involved the tongue base along with other sites such as supraglottic area, mesopharynx or 
hypopharynx. The “others” group represented 3 mesopharyngeal, 2 trans-glottic, 1 parotid and 
1 maxillary tumor. In total, 47 patients had cancers involving muscles responsible for tongue 
movement. Of the 74 patients in the surgical group, 36 had pectoralis major myocutaneous 
flap-, and 4 had radial forearm free flap reconstruction after radical resection of the tumors. 16 
patients underwent horizontal supraglottic resection of the larynx. 6 of these cases also had 
tongue base involvement. In 18 cases, the tumors were resected radically without flap 
reconstruction. 8 surgical resections in this group also involved the muscle of the tongue and 
in 5 cases significant portion of the meso-hypopharynx were resected. Involvement of 
hypopharynx by cancer was found in 16 surgical cases. Percutaneous endoscopic gastrostomy 
insertions took place under general anesthesia in 33 cases. The rest was performed in local 
anesthesia. Antibiotic was given to all patients in the preoperative and intraoperative group. 
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 No. of 
patients 
No. of 
PEG 
insertion 
No. of 
patients 
with 
multiple 
PEG 
insertions 
Duration of 
PEG 
feeding 
(days) 
Missing data 
(cases) 
Postoperative 
group 
59 73 8 307 
(6-2403) 
7 
Intraoperative 
group 
10 11 1 316 
(40-534) 
4 
Preoperative 
group 
5 6 1 81 
(10-143) 
3 
Palliative 
group 
24 25 1 142 
(5-554) 
3 
Table 4. 
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General anesthesia, antibiotic prophylaxis, complications 
 
Single dose antibiotic prophylaxis was used in 50 postoperative and in 14 palliative PEG 
procedures respectively.  Most often, antibiotic was chosen from the cephalosporin group.    
Antibiotics were not routinely administered to patients needed PEG replacement. 
 
Complications  Laryngoscopy 
assistance 
General 
anesthesia 
Antibiotic 
prophylaxis “in-use” Procedure-
related 
Postoperative 
group 
 (75 PEGs) 
 
1 
 
11 
 
50 
 
10 
 
7 (2 AB) 
Intraoperative 
group  
(10 PEGs) 
 
0 
 
10 
 
10 
 
0 
 
0 
Preoperative 
group  
(5 PEGs) 
 
5 
 
4 
 
5 
 
0 
 
1 
Palliative 
Group  
(25 PEGs) 
 
4 
 
8 
 
14 
 
0 
 
2 (1AB) 
Total 10 33 79 10 (8.77%) 10 (8.77%) 
2 AB: Two patients with antibiotic prophylaxis; 1 AB: one patient with antibiotic prophylaxis.  
Table 5.  
 
We experienced complications in 20 instances. “In-use” complications were dislodgement, 
fracture, and blockage of the feeding tube. Displacement and deterioration of the tubes 
occurred in 10 cases after a mean of 351 days (range 6-594 days). All 10 tubes were replaced. 
Peritonitis, peritubal leakage and wound infection were noted, among the procedure-related 
complications. 2 PEGs had to be removed for good and 2 needed replacement.  Each patient 
with complication was put on antibiotic therapy. The rate of procedure-related complication 
was 8.77%, while the overall complication rate was 17.54%. 36 PEG insertions were 
performed without antibiotic coverage while 79 were covered. Of the 36 PEGs, with no 
antibiotic prophylaxis 7 complications were noted versus the 3 among the 79 covered with 
antibiotics (19.44% vs. 3.79%). This was significant difference (CHI square test P<0.006). No 
complication was found in the intraoperative group. They all received antibiotics (Table 5).  
Four patients in the palliative group died within two weeks after PEG insertion. None of the 
deaths were related to the procedure. 
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Technical notes  
 
Always “pull” method was used to insert PEG, except for two cases with “push” technique. 
The introduction of the gastroscope into the stomach required the assistance of a Klensasser`s 
laryngoscope in 4 preoperative, 4 palliative and 1 postoperative case. PEG was inserted once 
via a cervical pharyngo-cutaneaus fistula. “Second-look” endoscopy was performed by a 
laryngofiberscope via the feeding tube in 12 instances. 
 
Outcome and mortality  
 
On 31 December 2003, 52 (53%) patients were dead and 30 (31%) were alive. No data were 
available in 16 cases. 26 patients were using PEG for feeding out of the 30 still alive. 4 patients 
had their PEGs removed permanently due to return of adequate per oral feeding. Death occurred 
within 2 weeks of PEG insertion in 4 palliative cases. None of the deaths were related to the PEG 
procedure. 48 patients died with their PEG still in place, while 4 had it removed earlier (Table 6).  
 
DISCUSSION 
 
Majority of patients with head and neck malignancies need artificial nutrition during the 
course of their disease. Nasogastric tube is sufficient for short-term (less than 4 weeks) 
nutritional support, however for long-term, percutaneous endoscopic gastrostomy is favored. 
The type of surgery, the tumor site, the extension, and the therapy determines the possible 
need for long-term feeding. These factors were studied in our oncology patients in order to 
define indication for PEG in head and neck surgical cases. The focus of our attention was on 
tumor site and surgical procedures that hinder swallowing the most. 
 
Indication for PEG in head and neck surgery 
 
The tumor registry and inpatient charts of patients hospitalized for treatment of head and neck 
cancers at Pécs University, Medical School, ENT Department were retrospectively examined. 
From January 1997 through December 2003, 1148 male and 177 female patients were 
admitted with head and neck malignancies. 23% of primary tumors involved the tongue and 
its muscles. Out of the 676 patients who underwent surgery, the resection involved the 
tongue, the tongue base or the tonsillo-lingual region on 187 (28 %) occasions.  
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PEG removed  
Died Alive No 
data 
 
Died with 
PEG 
 
Alive with 
PEG 
 
No data 
Postoperative 
group  
4 4 2 23 21 5 
Intraoperative 
group  
0 6 1 3 
Preoperative 
group  
0 0 1 1 1 2 
Palliative 
Group  
1 0 0 17 3 3 
Total 12 47 26 13 
Table 6. 
 
82 times pectoralis major myocutaneous flap and 19 times radial forearm free flaps were used 
for reconstructions. These flaps were utilized 87 times to reconstruct the excision site of the 
tongue-base, sublingual, or tonsillo-lingual regions. 69 (79%) of the patients who underwent 
such surgeries needed tube feeding more than 4 weeks in the postoperative period.  
Among the 74 patients with percutaneous endoscopic gastrostomy in the surgical groups, 47 
(64%) had tumors involving the muscular structure of the tongue and tongue base. The ratio 
was somewhat less in the non-surgical, palliative group (10 out of 24 patients, 42%). 
40 (54%) patients underwent pectoralis major myocutaneous flap, or radial forearm flap 
reconstructions after radical excision of their malignancies (Table 6). Tongue involvements 
by the tumor or the need of musculo-cutaneous skin flaps for reconstruction seem to be 
important indicators for possible poor swallowing capability in the postoperative period. 
Either or both of these factors were present in 73% of all the surgical case and 80% in the 
postoperative group.  
In our study, 6% of all head and neck oncology patients had supraglottic laryngeal 
malignancies. In the 7-year period, 47 horizontal supraglottic resections were performed, all 
requiring postoperative tube feeding. Out of the 47 supraglottic horizontal laryngectomies 16 
(34%) had percutaneous endoscopic gastrostomy tube inserted for long-term nutritional 
support. The cancer was localized in the supraglottic region in 10 cases, and it also involved 
the base of tongue in the remaining 6. Among all the patients with PEG in our postoperative 
group, 16 (30%) underwent horizontal supraglottic laryngectomy previously.  
16 patients in the surgical groups had tumors involving the hypopharynx. Due to the large 
extension of the tumor, 11 out of the 16 underwent radical surgical excision with skin flap 
reconstruction.  
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98 % of the patients who needed PEG feeding in the postoperative period had radical excision 
of cancers in the tongue region with or without skin flap reconstruction, or underwent 
supraglottic horizontal resection. The same figure was 86% among all the patients in the 
surgical groups receiving PEG (Chart 6). Excision of tumors in the lingual, sublingual, 
tonsillo-lingual or tongue base regions, all influence and hinder proper swallowing function. 
The need for different types of musculo-cutaneous skin flaps, also indicate that the resection 
was large and extensive. Besides, these musculo-cutaneous skin flaps cannot play an active 
role in the swallowing function, as do the tongue muscles, which they replace. They neither 
have muscle contracting capability nor innervations. The resection of the supraglottic region 
of the larynx also impairs proper deglutition and causes aspiration especially in elderly. Based 
on our findings, we indicate PEG, if extensive surgical resection of the extrinsic tongue 
muscles needed, with skin flap reconstruction. Besides, we also noticed that there is a high 
risk for prolonged swallowing difficulties and aspiration in patients with supraglottic 
horizontal resections, especially, if the tongue base also had to be resected due to tumor 
involvement. 
 
 
Tu. Ling.: Tongue cancer; Horizont: horizontal supraglottic laryngectomy; PMMF: Pectoralis 
major myocutaneous flap or radial forearm free flap 
Chart 6. 
 
In sum, I suggest the use of percutaneous endoscopic gastrostomy at the time of the definitive 
surgery, if 
• extensive resection of the extrinsic muscular structure of the tongue, with skin flap 
reconstruction is needed, or 
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• supraglottic horizontal laryngectomy, with partial resection of tongue- base is planned, 
or 
• extensive resection of mesopharynx or hypopharynx with skin flap reconstruction is 
carried out. 
 
Procedure failures, complications, antibiotic prophylaxis, general anesthesia 
 
The literature cites approximately 5 % failure rate for inserting PEG. Unsuccessful 
gastroscopy and the inability to transilluminate the stomach are the causes of failure. We were 
unable to perform PEG twice in our practice. In one case, we failed to achieve trans-
illumination of the abdomen, and in the other, we could not pass the gastroscope through the 
narrow pharynx, developed after surgery and radiotherapy. PEG complications are divided 
into two categories, major and minor. The mortality of PEG is around 1-2 %, and the 
morbidity rate is around 3-15 %. Peritonitis, hemorrhage, buried bumper syndrome, and 
gastrocolic fistula used to be cited as major (~3%), PEG, whereas wound infection, peristomal 
leak, hematoma as minor (5-15%) complications. Complications can also be divided into “in-
use” or “procedure-related”. “In-use” complications include problems such as feeding tube 
blockage, fracture, dislodgement, and detachment of bumpers or deterioration of the tube. In 
our series we needed to change the PEG 10 times due to “in-use” reasons. 7 times the tube 
dislodged, 2 times it fractured, and once blocked. These events happened 351 days in average 
(range 6-594 days) after PEG insertion. “Procedure-related” complications were supposed 
peritonitis, peritubal leak, and wound infection. We noticed peritubal leakage on 4 occasions 
with clinical symptoms of infection. The onsets of symptoms were on day 3, 6, 37, and 149. 
All the patients were put on systemic antibiotic therapy along with H-2 blockers. Enteral 
feeding was suspended for few days. Zinc paste was applied locally, to prevent maceration of 
the skin. Three times drainage bag was necessary to collect the discharge. We noted severe 
abdominal pain, tenderness, distension and peritubal discharge on day 5 in two cases. Patients 
also developed fever, nausea and fatigue. The abdomen became firm, with board-like rigidity 
around the stoma site. In these two cases we supposed the presence of local peritonitis. Same 
treatment was used as for peritstomal leakage, but we were also compelled to remove feeding 
tubes. Additionally, 4 times marked wound infections were noticed around the stoma site that 
developed 4, 4, 5, and 569 days after the PEG insertion. In all 4 cases local and systemic 
antibiotic treatment was started. PEG was also changed in one case.  
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To reduce the incidence of peristomal leak, “second-look” gastroscopy or “trans-tubal” fiberscopy 
are important for checking the tightness of the feeding tube at the time of insertion. The inner 
bumper of the feeding tube should be relatively tight in the first few days but later should be 
loosened. Too loose adjustment can lead to pneumoperitoneum or peritonitis, whereas too tight 
can cause cellulites or peristomal leak by pressure necrosis of the gastric wall. Four patients in the 
palliative group died within two weeks after PEG insertions (day 5, 5, 7, and 13), of causes 
unrelated to the gastrostomy tube insertion. The overall procedure-related complication rate was 
8.77 % (Table 5). At the beginning, antibiotic prophylaxis was not routinely used for our PEG 
procedures, but later we found it useful to prevent wound infections. 36 PEG insertions were 
performed without antibiotic coverage, while 78 patients received antibiotics, either for 
prophylaxis or for treatment. Usually, antibiotics from the cephalosporin family were chosen. Of the 
36 PEGs, with no antibiotic prophylaxis 7 complications were noted versus the 3 among the 79 
done under antibiotic coverage (19.44% vs. 3.79%). This was significant difference (CHI square 
test P< 0.005). No complication was found in the intraoperative group. They were all covered by 
antibiotics (Table 5). The use of perioperative antibiotics seemed to be an important factor in 
minimizing intra-abdominal infections, as well as preventing local exit site infections. We recommend 
the use of antibiotic prophylaxis as a general measure in percutaneous endoscopic gastrostomy.  
I recommend the insertion of PEG in the same anesthesia of the ablative surgery (e.g. 
intraoperative PEG), as no diagnosis, therapeutic plan, histology result or consent is yet 
available in the preoperative stage. 
In 9 cases, maneuvering the gastroscope to the esophagus was only possible by using a 
Kleinsasser`s type rigid laryngoscope. Direct visual control enabled us to guide the 
gastroscope manually through the tumor mass into the esophagus. 
In one postoperative case, both the gastroscope and the PEG tube was lead through cervical 
pharyngo-cutaneous fistula. 
 
Outcome and mortality 
 
In most of our patients, the decision to place PEG proved to be correct, as the majority of 
patients both in the surgical and palliative groups required enteral feeding on a long-term 
basis (Table 4). In 10 postoperative patients, PEG was removed permanently, as they had 
regained their ability of per oral feeding after 243 days in average (range 62-581 days). At the 
end of the study, 26 patients still used PEG for nutritional support. 48 patients expired of 
causes unrelated to the gastrostomy tube, with their PEG in situ at the time of death (Table 6). 
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THESES 
 
1. Percutaneous endoscopic gastrostomy is advised for long-term enteral feeding in head 
and neck cancer patients.  
  
2. The author recommends the use of percutaneous endoscopic gastrostomy in the first 
line, instead of nasogastric feeding tube for patients scheduled for the following 
surgeries: 
o Extensive resection of the extrinsic muscular structure of the tongue, with skin 
flap reconstruction. 
o Supraglottic horizontal laryngectomy, with partial resection of tongue- base. 
o Extensive resection of mesopharynx or hypopharynx with skin flap 
reconstruction. 
 
3. PEG insertion is recommended at the time of the ablative tumor surgery in the same 
general anesthesia. If difficult gastroscopy is suspected due to massive tumor load, 
intraoperative PEG is advised. 
 
4. “Second-look” gastroscopy should be performed for checking the correct position of 
the feeding tube and to exclude complications. The author recommends the use of his 
novel method (‘trans-tubal” endoscopy), instead of the second per oral gastroscopy. A 
laryngofiberscope can be passed through the inserted PEG tube for adequate visual 
control. 
 
5. Antibiotic prophylaxis is essential, when performing percutaneous endoscopic 
gastrostomy in head and neck cancer patients. Antibiotic prophylaxis results in 
statistically significant reduction of the infectious complications. 
 
6. PEG can be successfully performed via a cervical pharyngo-cutaneous fistula, if no 
other route is possible. 
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NOVELTIES 
 
1. The author introduced for the first time, the use of percutaneous endoscopic 
gastrostomy for the management of patients with head and neck cancers in Pécs 
University, Medical School, ENT Department.  
 
2. The author set up specific indications of PEG in head and neck cancer surgery, by 
working up the data of head and neck oncology cases treated in his department. 
 
3. He detailed the procedure of intraoperative PEG. Emphasized the importance of 
timing the PEG procedure and recommended intraoperative PEG placement after 
careful patient selection, based on the specific indications, set up by him. 
 
4. The author worked out and introduced first in the international literature a novel 
technique for “second-look”. Instead of passing the gastroscope to the stomach second 
time when performing PEG procedure, a flexible laryngofiberscope is passed through 
the inserted feeding tube. Please refer to the text regarding the multiple advantages of 
this technique. 
 
5. He published first in the international literature the possibility of performing PEG via 
a cervical pharyngo-cutaneous fistula formed after a major head and neck surgery. 
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